Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: Evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated

被引:26
作者
Lee, CH [1 ]
机构
[1] Univ No British Columbia, Dept Chem, Prince George, BC V2N 4Z9, Canada
关键词
P-glycoprotein; multidrug resistance; animal tissues; cycloheximide; transcription; post-transcription;
D O I
10.1023/A:1011086716568
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P-glycoprotein (Pgp) are a small family of plasma membrane proteins capable of transporting substrates across cell membranes. Class I and class II Pgp are able to transport drugs and have been shown to mediate multidrug resistance (MDR). Class III Pgp is a long chain phospholipid transporter and does not mediate MDR. The expression and regulation of Pgp genes in animal tissues are not well understood. In this study, the protein synthesis inhibitor cycloheximide was used as a tool to understand Pgp gene expression and regulation in animal tissues. The sensitive RNase protection assay was used to detect changes in Pgp mRNA levels and nuclear run-on assay was used to determine whether transcription or post-transcription is important. The results showed that cycloheximide significantly induced class II Pgp expression in all tissues examined. This was predominantly through post-transcriptional effect. In contrast, the relatively modest increase in class I Pgp expression by cycloheximide was found to be mainly due to increased transcriptional activity. On the other hand, cycloheximide induced class III Pgp expression in some tissues while caused decay of class III Pgp mRNA in other tissues. The transcriptional and post-transcriptional mechanisms exerted by cycloheximide on Pgp genes are discussed. These findings have implications for our understanding of gene regulation in animal tissues and MDR reversal strategies in vivo.
引用
收藏
页码:103 / 110
页数:8
相关论文
共 52 条
[1]  
ALTUVIA S, 1993, J BIOL CHEM, V268, P27127
[2]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[3]   Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression [J].
Bargou, RC ;
Jurchott, K ;
Wagener, C ;
Bergmann, S ;
Metzner, S ;
Bommert, K ;
Mapara, MY ;
Winzer, KJ ;
Dietel, M ;
Dorken, B ;
Royer, HD .
NATURE MEDICINE, 1997, 3 (04) :447-450
[4]   Characterization of the rat mdr2 promoter and its regulation by the transcription factor Sp1 [J].
Brown, PC ;
Silverman, JA .
NUCLEIC ACIDS RESEARCH, 1996, 24 (16) :3235-3241
[5]   mRNA degradation - a tale of poly(A) and multiprotein machines [J].
Carpousis, AJ ;
Vanzo, NF ;
Raynal, LC .
TRENDS IN GENETICS, 1999, 15 (01) :24-28
[6]   Differences between nuclear run-off and mRNA levels for multidrug resistance gene expression in the cephalocaudal axis of the mouse Intestine [J].
Chianale, J ;
Vollrath, V ;
Wielandt, AM ;
Miranda, S ;
Gonzalez, R ;
Fresno, AM ;
Quintana, C ;
Gonzalez, S ;
Andrade, L ;
Guzman, S .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1264 (03) :369-376
[7]  
CHIN KV, 1990, J BIOL CHEM, V265, P221
[8]   MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53 [J].
CHIN, KV ;
UEDA, K ;
PASTAN, I ;
GOTTESMAN, MM .
SCIENCE, 1992, 255 (5043) :459-462
[9]  
CHIN KV, 1990, CELL GROWTH DIFFER, V1, P361
[10]   THE 3 MOUSE MULTIDRUG RESISTANCE (MDR) GENES ARE EXPRESSED IN A TISSUE-SPECIFIC MANNER IN NORMAL MOUSE-TISSUES [J].
CROOP, JM ;
RAYMOND, M ;
HABER, D ;
DEVAULT, A ;
ARCECI, RJ ;
GROS, P ;
HOUSMAN, DE .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) :1346-1350